This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 1985.
Company Filing History:
Years Active: 1985
Title: Jesse R Bewley: Innovator in Angiogenesis Inhibition
Introduction
Jesse R Bewley is a notable inventor based in Indianapolis, IN (US). She has made significant contributions to the field of medical science, particularly in the area of angiogenesis inhibitors. Her innovative work has the potential to impact various therapeutic applications.
Latest Patents
Jesse holds a patent for "Ascorbic acid ethers in angiogene - Ethers of ascorbic and isoascorbic acid and ketals and acetals thereof, angiogenesis inhibitors." This patent highlights her research and development efforts in creating compounds that can inhibit angiogenesis, which is crucial for treating various diseases.
Career Highlights
Jesse is currently employed at Eli Lilly and Company, a leading pharmaceutical company known for its commitment to innovation in healthcare. Her role at Eli Lilly allows her to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Throughout her career, Jesse has worked alongside esteemed colleagues such as Stephen L Briggs and Gary A Koppel. These collaborations have further enhanced her research and development efforts, leading to advancements in her field.
Conclusion
Jesse R Bewley is a pioneering inventor whose work in angiogenesis inhibitors showcases her dedication to advancing medical science. Her contributions at Eli Lilly and Company and her innovative patent reflect her significant impact on the industry.